Education
About Us
Working with TipRanks
Follow Us
DHS - ETF AI Analysis
Top Page
WisdomTree U.S. High Dividend Fund (DHS)
Rating:71Outperform
Price Target:
$112.22
Positive Factors
Strong Top Holdings
Several of the largest positions, like Johnson & Johnson and AbbVie, have delivered strong year-to-date performance, supporting the fund’s returns.
Sector Diversification
The ETF is spread across multiple sectors, including Health Care, Financials, and Consumer Defensive, reducing reliance on any single industry.
Reasonable Expense Ratio
The fund’s expense ratio is relatively low, making it cost-effective compared to many actively managed funds.
Negative Factors
Over-Concentration in U.S. Market
The ETF is almost entirely focused on U.S. companies, limiting exposure to international markets and diversification.
Energy Sector Sensitivity
Significant exposure to the Energy sector could make the fund vulnerable to oil price fluctuations and sector-specific risks.
Mixed Performance Among Holdings
While some holdings have performed well, others like AT&T and PepsiCo have shown weaker year-to-date growth, potentially dragging on overall returns.
DHS vs. SPDR S&P 500 ETF (SPY)
AUM1.29B
RegionNorth America
Expense Ratio0.38%
Beta0.51
IssuerWisdomTree
Inception DateJun 16, 2006
Dividend Yield3.35%
Asset ClassEquity
Index TrackedWisdomTree U.S. High Dividend Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume23,937
30 Day Avg. Volume24,640
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
112.22Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering366
DHS Summary
The WisdomTree U.S. High Dividend Fund (DHS) is an ETF that focuses on U.S. companies known for paying high dividends. It follows the WisdomTree U.S. High Dividend Index and includes well-known companies like Johnson & Johnson and AbbVie. This fund is ideal for investors looking to earn steady income from dividends while gaining exposure to a mix of sectors such as healthcare, financials, and consumer defensive. However, since it heavily relies on dividend-paying stocks, its performance can be affected by market conditions or changes in dividend policies.
How much will it cost me?The WisdomTree U.S. High Dividend Fund (DHS) has an expense ratio of 0.38%, meaning you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to focus on high dividend-paying stocks, which requires more research and management. It’s designed for investors seeking income and stability through dividends.
What would affect this ETF?The WisdomTree U.S. High Dividend Fund (DHS) could benefit from stable or rising interest in dividend-paying stocks, especially during periods of economic uncertainty when investors seek reliable income sources. However, it may face challenges if interest rates rise significantly, as higher yields on bonds could make dividend-focused investments less attractive. Additionally, its heavy exposure to sectors like Health Care and Energy means it could be impacted by regulatory changes or fluctuations in commodity prices.
DHS Top 10 Holdings
The WisdomTree U.S. High Dividend Fund (DHS) leans heavily on health care, financials, and consumer defensive sectors, with names like Johnson & Johnson and AbbVie providing steady support thanks to robust earnings and growth prospects. Energy giants Exxon Mobil and Chevron have shown mixed performance, with strategic initiatives offsetting short-term market challenges. Meanwhile, Philip Morris and AT&T are holding the fund back, as high leverage and bearish technical indicators weigh on their momentum. With its U.S.-focused portfolio, DHS offers a stable income stream but remains sensitive to sector-specific headwinds.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 6.20% | $79.97M | $458.73B | 17.76% | 78 Outperform | |
| AbbVie | 5.33% | $68.83M | $402.76B | 20.22% | 64 Neutral | |
| Philip Morris | 5.25% | $67.77M | $245.35B | 17.40% | 62 Neutral | |
| Exxon Mobil | 4.97% | $64.17M | $491.94B | -2.49% | 79 Outperform | |
| Altria Group | 4.22% | $54.42M | $108.64B | 26.84% | 68 Neutral | |
| Chevron | 3.94% | $50.79M | $318.49B | 3.15% | 73 Outperform | |
| PepsiCo | 3.80% | $49.02M | $207.22B | -10.13% | 78 Outperform | |
| AT&T | 3.13% | $40.37M | $179.76B | 15.47% | 72 Outperform | |
| International Business Machines | 3.04% | $39.18M | $287.39B | 47.05% | 77 Outperform | |
| Gilead Sciences | 2.80% | $36.10M | $150.06B | 35.72% | 78 Outperform |
DHS Technical Analysis
Positive
―
Price Trends
100.04
Positive
98.07
Positive
95.64
Positive
Market Momentum
0.19
Negative
54.90
Neutral
69.66
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DHS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 100.22, equal to the 50-day MA of 100.04, and equal to the 200-day MA of 95.64, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 54.90 is Neutral, neither overbought nor oversold. The STOCH value of 69.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DHS.
DHS Peer Comparison
Comparison Results
Performance Comparison
DHS
WisdomTree U.S. High Dividend Fund
100.69
9.39
10.28%
SCHD
Schwab US Dividend Equity ETF
―
―
―
FVD
First Trust Value Line Dividend Index Fund
―
―
―
SPYD
SPDR Portfolio S&P 500 High Dividend ETF
―
―
―
FDL
First Trust Morningstar Dividend Leaders Index Fund
―
―
―
PEY
Invesco High Yield Equity Dividend Achievers ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents